Invictus MD Strategies Corp Stock Toronto S.E.
Equities
GENE
CA46183X2086
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CAD | - |
Sales 2018 | 2.36 3.24 | Sales 2019 | 4.69 6.44 | Capitalization | 104M 142M |
---|---|---|---|---|---|
Net income 2018 | -19M -26.06M | Net income 2019 | -35M -48.01M | EV / Sales 2018 | 45,833,024 x |
Net cash position 2018 | 37.59M 51.57M | Net Debt 2019 | 3.85M 5.27M | EV / Sales 2019 | 22,877,117 x |
P/E ratio 2018 |
-5.87
x | P/E ratio 2019 |
-2.45
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 6.83% |
Managers | Title | Age | Since |
---|---|---|---|
Imran Haider
CEO | Chief Executive Officer | - | - |
Trevor Dixon
BRD | Director/Board Member | - | 19-05-08 |
Larry Heinzlmeir
IRO | Public Communications Contact | - | 17-01-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Trevor Dixon
BRD | Director/Board Member | - | 19-05-08 |
Jagdeep Gupta
BRD | Director/Board Member | - | 22-02-21 |
Greg Macdonald
BRD | Director/Board Member | - | 21-01-25 |
1st Jan change | Capi. | |
---|---|---|
+34.37% | 5.8B | |
-27.13% | 3.92B | |
+4.75% | 3.28B | |
-20.80% | 2.77B | |
-10.70% | 2.26B | |
+49.04% | 1.95B | |
-16.86% | 1.52B | |
+49.16% | 1.49B | |
-9.87% | 1.49B |
- Stock Market
- Equities
- IVITF Stock
- GENE Stock